The Society of Surgical Oncology (SSO) maintains disease site workgroups (DSWGs) to represent the various disease sites associated with surgical oncology in the USA. Experts in DSWGs have formulated five measures impacting the largest number of patients with breast cancer, colorectal cancer, and melanoma. Cancer therapy, screening and surveillance is largely based on different diagnostic procedure.
Recommending diagnostic tests that have no evidence based benefit may burden the patient with cost leading to non-compliance to treatment or even a poor therapeutic outcome in some cases. Following are the five wise recommendation to use diagnostic procedure in breast cancer, colorectal cancer and melanoma. Avoid routine use of node biopsy in elder node negative women Don’t routinely use sentinel node biopsy in clinically node-negative women ≥70 years of age with hormone receptor-positive…
